# Facilitating Rapid Naltrexone Initiation

> **NCT03345173** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **New York State Psychiatric Institute** · enrollment: 100 (estimated)

## Conditions studied

- Opioid Dependence

## Interventions

- **DRUG:** CI-581-a
- **DRUG:** CI-581-b

## Key facts

- **NCT ID:** NCT03345173
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-11-25
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03345173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03345173, "Facilitating Rapid Naltrexone Initiation". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03345173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*